Biotech Values

[iwfal]

CLDX -

You can analyze the statistics any way you want--and I appreciate you sharing your knowledge of the field and your critical thoughts with the board--but clearly this drug shows activity in TNBC.

I really am at a loss for how to further explain it. So you'll just have to trust me that the Triple Negative without High G had NO PFS benefit. And the High G patients without Triple Negative status weren't much better.

Only the small group of High G AND Triple Negative showed a meaningful (if fact VERY good) PFS benefit - albeit small subgroup and post hoc-ish.